Gut Microbiota-Derived Diaminopimelic Acid Promotes the NOD1/RIP2 Signaling Pathway and Plays a Key Role in the Progression of Severe Acute Pancreatitis
Open Access
- 22 June 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 12, 838340
Abstract
Impaired intestinal barrier function and gut microbiota dysbiosis are believed to be related to exacerbation of acute pancreatitis (AP). As a bacterial cell wall peptidoglycan component, diaminopimelic acid (DAP) is a specific ligand of NOD1 that regulates the NOD1/RIP2/NF-kB signaling pathway. Here, we investigated the role of DAP in the crosstalk between the gut microbiota and pancreas during the occurrence of AP. Upregulation of NOD1/RIP2/NF-kB and elevated serum DAP levels were found in severe AP (SAP) model rats. The accumulation of DAP in SAP patients corroborated its ability to serve as an indicator of disease severity. Subsequently, SAP rats were treated with oral administration of the traditional Chinese medicine Qingyi Keli (QYKL) as well as neomycin, which can widely eliminate DAP-containing bacteria. Both QYKL and neomycin intervention ameliorated intestinal and pancreatic damage and systemic inflammation in SAP rats. Through 16S rDNA sequencing, we found that QYKL could rehabilitate the gut microbiota structure and selectively inhibit the overgrowth of enteric bacteria, such as Helicobacter and Lactobacillus, in SAP rats without affecting some protective strains, including Romboutsia and Allobaculum. Interestingly, we demonstrated that the decrease in serum DAP was accompanied by suppression of the NOD1/RIP2/NF-kB signaling pathway in both the intestine and pancreas of the two intervention groups. Taken together, these results suggested that the gut microbiota-DAP-NOD1/RIP2 signaling pathway might play a critical role in the progression of AP and that SAP could be alleviated via intervention in the signaling pathway. Our work provides new potential early warning indicators of SAP and targets for intervention.Keywords
Funding Information
- National Natural Science Foundation of China (81873156, 82004152)
- National Key Research and Development Program of China (2018YFE0195200)
This publication has 50 references indexed in Scilit:
- Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensusGut, 2012
- Role of the Gut Barrier in Acute PancreatitisJournal of Clinical Gastroenterology, 2012
- Sensing of Commensal Organisms by the Intracellular Sensor NOD1 Mediates Experimental PancreatitisImmunity, 2012
- Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunityNature Medicine, 2010
- Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entryNature Immunology, 2009
- Impact of toll-like receptor 4 on the severity of acute pancreatitis and pancreatitis-associated lung injury in miceGut, 2009
- Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial TaxonomyApplied and Environmental Microbiology, 2007
- Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial PeptidoglycanScience, 2003
- An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acidNature Immunology, 2003
- NODs: intracellular proteins involved in inflammation and apoptosisNature Reviews Immunology, 2003